The insulin/insulin-like growth factor-1 signaling pathway of Caenorhabditis elegans regulates larval diapause and adult lifespan through the sole insulin receptor-like protein, DAF-2. In the present study, the physiological function and expression pattern of INS-17, one of the C. elegans insulin-like peptides, were examined by disruption and overexpression of the gene, and by the use of a reporter gene. INS-17 might function as a DAF-2 antagonist in the regulation of larval diapause, but not of the adult lifespan. The reporter protein was intensively expressed during larval diapause. It showed a drastic decrease in amount after larval diapause, which matches well the physiological function of INS-17.
In the nematode Caenorhabditis elegans (C. elegans), environmental conditions determine whether the worm develops directly into an adult or is arrested at the alternative L3 larval stage to form a dauer larva. Dauer larvae are induced by harsh environments such as starvation, a high concentration of dauer pheromones secreted by crowded worms, or high temperature. 1, 2) The worms can survive in these adverse conditions because of their distinctive adaptive morphological, behavioral, and metabolic features. When environmental conditions improve, the worms resume normal growth. This survival system, known as larval diapause, is controlled by pathways including the transforming growth factor (TGF)-related pathway 3) and the insulin/insulin-like growth factor (IGF)-1 signaling (IIS) pathway. In these pathways, the IIS pathway plays an important role in controling not only larval diapause but also adult lifespan. 4) It contains the sole C. elegans insulin/IGF-1 receptor-like protein, DAF-2, 4) and the forkhead box O (FOXO) transcription factor homolog, DAF-16. 5, 6) DAF-2 inactivation results in DAF-16 nuclear translocation, [7] [8] [9] which not only induces larval diapause but also leads to increased longevity. [10] [11] [12] Thus IIS is an important pathway controlling larval diapause and adult lifespan in C. elegans.
DAF-2-ligands, insulin-like peptides (ILPs), control the activation and inactivation of this signaling pathway. To date, 40 insulin-like genes have been identified in the C. elegans genome, and the predicted peptides encoded by the genes are classified into type-, -, andaccording to their predicted disulfide bond patterns. 13, 14) Type-ILPs have three canonical disulfide bonds that are conserved among vertebrate insulin family peptides. We have identified ins-18 (Ceinsulin-1) and ins-17 (Ceinsulin-2), which encode type-ILPs, INS-18 and INS-17 respectively. 15, 16) These ILPs are structurally similar to each other, and include a characteristic insertion of three amino acid residues (-Pro-Pro-Gly-) in the B domain. In addition, their predicted tertiary structures match well. Our recent study indicated that INS-18 functions as a DAF-2 antagonist and is required not only for larval diapause but also for extension of the adult lifespan. 17) In addition, INS-18 is intensively expressed in neurons at the diapause stage, and shows a drastic decrease in amount after recovery from diapause, but further examination of INS- 17 has not yet been done.
In this study, first we examined the physiological function of INS-17 by gene disruption and overexpression. Subsequently we examined the spatio-temporal expression of INS-17 and compared it with that of INS-18. In addition, we investigated the regulation of ins-17 transcription.
To elucidate the physiological functions of INS-17, first we disrupted the ins-17 gene by the TMP/UV method. 18) To screen a deletion mutant by sib-screening, we used the primer sets shown in Communication mutant did not synthesize the INS-17 peptide. This deletion mutant was named tm790 (Fig. 1A) . The mutant was backcrossed with wild-type animals 5 times to remove an unexpected mutation. Then this backcrossed worm (the ins-17 KO animal) was used in subsequent experiments. We also produced nematode strains to rescue the defect caused by ins-17-deletion and to overexpress ins-17. For producing these strains, the ins-17 transgene (ins-17p::ins-17) was constructed as follows: a genomic fragment containing the ins-17 coding region and a 5.4-kb upstream sequence was amplified by PCR and inserted into pGEM Ò T-easy vector (Promega, WI). This ins-17 transgene was verified by sequencing, and then microinjected (15 ng/ mL) into the germ line 19) of ins-17 KO and wild-type animals along with the eft-3p::venus marker (20 ng/mL). The wild-type animals injected with this marker did not show any influence on larval diapause or adult lifespan.
Next we examined to determine whether INS-17 modulates larval diapause. When ins-17 KO animals were reared on standard nematode growth medium (NGM) plates seeded with Escherichia coli OP50 bacteria at 20 C, 20) the animals showed no larval diapause. Hence we measured the appearance of dauer larvae in the presence of a crude extract of dauer pheromones prepared as described previously to produce a diapause-inducing condition. 21) NGM plates containing the extract at a final concentration of 1% (v/v) were seeded with Escherichia coli OP50 bacteria. Five to 10 adult hermaphrodites were placed on the plates and incubated at 20 C. After a short period of egg laying, adult worms were removed from the plates and the progeny were allowed to develop to the young-adult stage at 20 C. We identified dauers (worms in diapause) and non-dauers using a microscope and counted them. The dauer stage was confirmed by the presence of dark pigment granules, constriction of the body and pharynx, and a loss of pharyngeal pumping. As shown in Fig. 1B , ins-17 deletion resulted in a 32.8% reduction in the larval diapause as compared to the wild-type animals. This reduction was reversed by injection of the ins-17 transgene. There was no statistically significant difference between the ins-17 rescue animals and wild-type animals (p ¼ 0:247), resulting in a rescue of the phenotype. In addition, ins-17-overexpressing (ins-17 O/E) animals generated by ins-17 transgene injection into wild-type animals showed a 35.4% increase in larval diapause as compared to the wild-type animals. Deletion and overexpression of ins-17 showed opposite phenotypes in larval diapause, as expected. These results suggest that INS-17 is involved in the regulation of the larval diapause.
Recently, it was reported that INS-6 and DAF-28 modulate larval diapause to function as agonists in the same neurons. 22) In other words, several insulin-like peptides might modulate larval diapause cooperatively through the IIS pathway. Our previous study reported that INS-18 is required for larval diapause as well as longevity. 17) Hence, we attempted to determine whether INS-17 and INS-18 contribute cooperatively to the regulation of larval diapause. For this, first we examined the effect of the ins-17;ins-18 double mutation on larval diapause. A double-mutant animal was produced by crossing the single mutants (the ins-17 KO and tm339 animals). As shown in Fig. 1B, ins-18 deletion (tm339) resulted in a 58.6% reduction in larval diapause as compared to the wild-type animals. This reduction matches well the results of our previous study. 17) These results suggest that INS-17 is lesser relevance to larval diapause than INS-18. In addition, the ins-17;ins-18 double mutant animals showed a 71.6% reduction in larval diapause as compared to the wildtype animals. Although more reduction of larval diapause was observed in the double mutant animals, no statistically significant difference was found between the double mutant animals and the ins-18 mutant animals (p ¼ 0:264). Then we investigated the effects of ins-17 deletion and overexpression on adult lifespan. Neither deletion nor overexpression showed any effect on it (Table S2 and Fig. S1 reduced larval diapause in the presence of dauer pheromone, probably due to the relative dominance of agonist binding to DAF-2. Overexpression of ins-17 induced larval diapause, probably due to high levels of INS-17 binding to DAF-2. Based on these data, we assumed that INS-17 can function as a DAF-2 antagonist at the larval 1 and 2 stages.
The information as to when and where the hormonal peptides are expressed is important for further functional analysis. Hence we investigated the spatio-temporal expression of INS-17 by generating transgenic animals expressing VENUS driven by the intact ins-17 promoter. For this, we constructed a reporter gene as follows: For an ins-17 reporter gene (ins-17p::venus), a genomic fragment containing a 5.3-kb upstream sequence of the initial ATG in ins-17 was amplified by PCR from genomic DNA and inserted into pPD venus vector, which contains a multiple cloning site followed by the venus 23) coding sequence and the unc-54 3 0 -untranslated region ( Fig. 2A) . The primers used for PCR amplification are listed in supplemental manuscript (Table S1 ). To produce animals expressing ins-17p::VENUS, the ins-17 reporter gene and co-injection marker pRF4 [rol-6(su1006)] (15 ng/mL, each) were microinjected into the germ line of wild-type animals. 24) Fluorescent images were obtained with an IX71 differential interference fluorescence microscope (Olympus, Tokyo). On analysis of the expression pattern of the VENUS in this study, we observed that it was expressed in head neurons at every developmental stage. At the adult stage, VENUS expression was also seen in the uterus (Fig. 2B) , suggesting the hypothesis that INS-17 is involved in reproduction. However, when we measured the numbers of laid eggs of the ins-17 KO animals, we did not find any significant difference with the wild-type animals (data not shown). At the dauer stage, VENUS was more intensively expressed in the head and tail neurons than at normal developmental stages. VENUS expression became weak during recovery from the dauer stage (Fig. 2C) . This expression pattern matches well the proposed physiological function of INS-17. In a further observation, VENUS was expressed in at least amphid neurons (not chemosensory neurons), the ventral nerve code, and AVG interneurons at the dauer stage (Fig. S2) . We identified cells according to DiI staining and the anatomy database for C. elegans. 25) As far as we know, INS-17 is the sole ILP that shows such expression patterns among 40 ILPs. 13) Environmental cues, including dauer pheromones, might induce INS-17 expression in interneurons through chemosensory neurons releasing a second messenger, leading to the dauer stage.
As fragment containing a 5.2-kb upstream sequence of the initial ATG in ins-18 was amplified by PCR from genomic DNA and inserted into the pHK mrfp vector, which contains a multiple cloning site followed by the mRFP coding sequence and the unc-54 3 0 -untranslated region (Fig. 2A) . The primers used for, PCR amplifications are listed in the supplemental manuscript (Table S1 ). To produce animals expressing both ins17p::VENUS and ins-18p::mRFP, a mixture of both reporter genes and co-injection marker pRF4 [rol-6(su1006)] (15 ng/mL, each) was microinjected into the germ line of the wild-type animals. 24) Fluorescent images were obtained with an FV10i0 confocal laser scanning microscope (Olympus). We focused on the dauer stage, since INS-17 as well as INS-18 is required for larval diapause. In the merged image, a few cells appeared to express both (Fig. 2D) . However, the 3D images indicated that VENUS was expressed in cells different from those in which mRFP was seen. Hence we concluded that INS-17 and INS-18 were produced in the respective cells and separately induced larval diapause, unlike INS-6 and DAF-28.
22)
Finally, we investigated the regulation of ins-17 transcription. At the dauer stage, DAF-16, a transcription factor downstream of the DAF-2 receptor, is translocated into the nucleus, [7] [8] [9] suggesting that nuclear DAF-16 promotes transcription of the genes required for larval diapause and suppresses transcription of the genes that prevent diapause. Hence we hypothesized that ins-17 transcription is upregulated by DAF-16 due to the proposed physiological function of INS-17 as a DAF-2 antagonist. In fact, the DAF-16 consensus sequences (GTAAAt/cA and CTTATCA) have been identified in the ins-17 upstream sequence. 26) To test this hypothesis, we measured the relative amounts of the ins-17 transcript in the absence and the over-presence of nuclear DAF-16 by qRT-PCR. For this, we utilized the daf-16(mu86) mutant, in which the gene is deleted and hence DAF-16 is never produced. We also used the daf-2(e1370) mutant, containing a temperature-sensitive point mutation (P1465S) located in the intercellular kinase domain. 4) In this mutant, IIS signaling is reduced, leading to nuclear localization of DAF-16 at nonpermissive temperatures due to incomplete DAF-2 function. Synchronized L1 larvae (10,000-15,000) were grown to the L2 stage over 12 h at 20 C (a nonpermissive temperature for the daf-2 mutant). Subsequently, the grown animals were stored in 100 mL of RNAlater solution (Takara, Shiga, Japan) at 4 C. mRNA samples were prepared using an Isogen Poly(A) þ Isolation Pack (Nippon Gene, Tokyo), and cDNA was synthesized using a cDNA synthesis kit (Roche, Mannheim, Germany). The PCR mixture consisted of 0.3 mM primers, 0.5 mL of dT-30-primed cDNAs, and 5 mL of THUNDERBIRDÔ SYBR Ò qPCR Mix (Toyobo, Osaka). qPCR was monitored using a LineGene real-time thermal cycler (BioFlux, Tokyo) under the following reaction conditions: denaturation, 95 C, 15 s; annealing, 55 C, 15 s; extension, 72 C, 30 s (40 cycles). act-1 was used as internal control. The primers used for qPCR amplification are listed in the supplemental manuscript (Table S1 ). Amplification was performed in triplicate. Initial data analysis was carried out using the Fluorescent Quantitative Detection System (BioFlux, Tokyo), which calculated Ct values and extrapolated the relative levels of the PCR products from standard curves. To discount the possibility of contamination and of primer dimers, we analyzed the melt curves. As shown in Fig. 3 , the amount of ins-17 transcript decreased to approximately 0.34-fold as compared to that of the wild-type animals, indicating that a lack of the DAF-16 transcription factor suppresses ins-17 expression. This confirms our hypothesis. In contrast, the ins-17 transcript levels in the daf-2(e1370) mutants increased to 2.1-fold as compared to that for the wild-type animals. We also confirmed this phenotype by VENUS expression. ins-17p::VENUS was downregulated in the daf-16(mu86) mutant background, but upregulated in the daf-2(e1370) mutant background (Fig. S3) . These results indicate that ins-17 transcription is positively regulated by DAF-16 nuclear translocation, like ins-18 transcription. 17) In this study, we elucidated the involvement of INS-17 in the regulation of larval diapause, but not of adult lifespan, and then we assumed that INS-17 can function as a DAF-2 antagonist. INS-17 is of lesser relevance to larval diapause than INS-18, another DAF-2 antagonist. These ILPs, which are intensively expressed in different cells during the dauer stage, probably modulate diapause separately. INS-17 modulates only larval diapause, while INS-18 modulates adult lifespan in addition to larval diapause through the DAF-2 receptor. On the other hand, the expression of both genes is regulated by DAF-16. Recently, it was reported that DAF-16 isoforms selectively function to modulate larval diapause and/or adult lifespan. 27) Although the underlying mechanism that causes a physiological difference between INS-17 and INS-18 remains unknown, these ILPs might regulate larval diapause and/or adult lifespan through different DAF-16 isoforms. This study perhaps provides insight into the hormonal regulation of larval diapause and adult lifespan in C. elegans. The amounts of ins-17 transcripts in the wild-type, daf-16(mu86) mutant, and daf-2(e1370) mutant animals at the L2 stage were quantified relatively by qRT-PCR. Columns indicate relative values, standardized by the amount of transcript of the wild-type animal. Each mean AE SEM includes at least three independent experiments. Multiple comparisons between groups were made by Dunnett's test ( Ã p < 0:01).
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